nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—ABCB1—schizophrenia	0.73	1	CbGaD
Lenalidomide—TNFSF11—blood—schizophrenia	0.0121	0.0743	CbGeAlD
Lenalidomide—TNFSF11—endocrine gland—schizophrenia	0.0105	0.0644	CbGeAlD
Lenalidomide—CDH5—blood—schizophrenia	0.00913	0.0559	CbGeAlD
Lenalidomide—CDH5—midbrain—schizophrenia	0.00901	0.0552	CbGeAlD
Lenalidomide—CRBN—forebrain—schizophrenia	0.00867	0.0531	CbGeAlD
Lenalidomide—CDH5—Cell junction organization—CLDN5—schizophrenia	0.00832	0.0933	CbGpPWpGaD
Lenalidomide—CRBN—telencephalon—schizophrenia	0.00797	0.0488	CbGeAlD
Lenalidomide—CDH5—endocrine gland—schizophrenia	0.00792	0.0485	CbGeAlD
Lenalidomide—CDH5—nervous system—schizophrenia	0.00741	0.0454	CbGeAlD
Lenalidomide—CDH5—central nervous system—schizophrenia	0.00713	0.0437	CbGeAlD
Lenalidomide—CDH5—cerebellum—schizophrenia	0.00697	0.0427	CbGeAlD
Lenalidomide—CRBN—gonad—schizophrenia	0.00665	0.0407	CbGeAlD
Lenalidomide—CDH5—Signaling events mediated by VEGFR1 and VEGFR2—FES—schizophrenia	0.00659	0.0739	CbGpPWpGaD
Lenalidomide—CDH5—Cell-Cell communication—CLDN5—schizophrenia	0.00593	0.0664	CbGpPWpGaD
Lenalidomide—CRBN—blood—schizophrenia	0.0058	0.0355	CbGeAlD
Lenalidomide—CRBN—midbrain—schizophrenia	0.00573	0.0351	CbGeAlD
Lenalidomide—CDH5—brain—schizophrenia	0.00566	0.0347	CbGeAlD
Lenalidomide—Pomalidomide—TNF—schizophrenia	0.0052	0.307	CrCbGaD
Lenalidomide—CRBN—endocrine gland—schizophrenia	0.00503	0.0308	CbGeAlD
Lenalidomide—CRBN—nervous system—schizophrenia	0.00471	0.0288	CbGeAlD
Lenalidomide—CRBN—central nervous system—schizophrenia	0.00453	0.0277	CbGeAlD
Lenalidomide—CRBN—cerebellum—schizophrenia	0.00443	0.0271	CbGeAlD
Lenalidomide—PTGS2—blood plasma—schizophrenia	0.00431	0.0264	CbGeAlD
Lenalidomide—Pomalidomide—CYP1A2—schizophrenia	0.00381	0.225	CrCbGaD
Lenalidomide—CRBN—brain—schizophrenia	0.0036	0.022	CbGeAlD
Lenalidomide—CDH5—S1P2 pathway—FOS—schizophrenia	0.00341	0.0382	CbGpPWpGaD
Lenalidomide—Thalidomide—TNF—schizophrenia	0.00335	0.198	CrCbGaD
Lenalidomide—TNFSF11—IL6-mediated signaling events—FOS—schizophrenia	0.0028	0.0314	CbGpPWpGaD
Lenalidomide—ABCB1—blood plasma—schizophrenia	0.00267	0.0163	CbGeAlD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—EGR3—schizophrenia	0.00248	0.0278	CbGpPWpGaD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—FOS—schizophrenia	0.00247	0.0277	CbGpPWpGaD
Lenalidomide—Thalidomide—CYP1A2—schizophrenia	0.00245	0.145	CrCbGaD
Lenalidomide—PTGS2—forebrain—schizophrenia	0.00236	0.0145	CbGeAlD
Lenalidomide—PTGS2—telencephalon—schizophrenia	0.00217	0.0133	CbGeAlD
Lenalidomide—Pomalidomide—ABCB1—schizophrenia	0.0021	0.124	CrCbGaD
Lenalidomide—ABCB1—Codeine and Morphine Metabolism—CYP2D6—schizophrenia	0.00171	0.0191	CbGpPWpGaD
Lenalidomide—PTGS2—blood—schizophrenia	0.00158	0.00966	CbGeAlD
Lenalidomide—PTGS2—midbrain—schizophrenia	0.00156	0.00954	CbGeAlD
Lenalidomide—ABCB1—forebrain—schizophrenia	0.00146	0.00894	CbGeAlD
Lenalidomide—PTGS2—endocrine gland—schizophrenia	0.00137	0.00838	CbGeAlD
Lenalidomide—ABCB1—telencephalon—schizophrenia	0.00134	0.00822	CbGeAlD
Lenalidomide—CDH5—VEGFR2 mediated vascular permeability—AKT1—schizophrenia	0.00129	0.0144	CbGpPWpGaD
Lenalidomide—PTGS2—nervous system—schizophrenia	0.00128	0.00785	CbGeAlD
Lenalidomide—PTGS2—Spinal Cord Injury—RTN4R—schizophrenia	0.00125	0.014	CbGpPWpGaD
Lenalidomide—PTGS2—central nervous system—schizophrenia	0.00123	0.00755	CbGeAlD
Lenalidomide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NOS1—schizophrenia	0.00123	0.0138	CbGpPWpGaD
Lenalidomide—PTGS2—cerebellum—schizophrenia	0.00121	0.00738	CbGeAlD
Lenalidomide—TNFSF11—IL6-mediated signaling events—AKT1—schizophrenia	0.00112	0.0126	CbGpPWpGaD
Lenalidomide—ABCB1—gonad—schizophrenia	0.00112	0.00686	CbGeAlD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—AKT1—schizophrenia	0.000989	0.0111	CbGpPWpGaD
Lenalidomide—PTGS2—brain—schizophrenia	0.00098	0.006	CbGeAlD
Lenalidomide—ABCB1—blood—schizophrenia	0.000976	0.00598	CbGeAlD
Lenalidomide—ABCB1—midbrain—schizophrenia	0.000964	0.0059	CbGeAlD
Lenalidomide—ABCB1—endocrine gland—schizophrenia	0.000847	0.00519	CbGeAlD
Lenalidomide—ABCB1—nervous system—schizophrenia	0.000793	0.00485	CbGeAlD
Lenalidomide—ABCB1—central nervous system—schizophrenia	0.000763	0.00467	CbGeAlD
Lenalidomide—ABCB1—cerebellum—schizophrenia	0.000746	0.00457	CbGeAlD
Lenalidomide—PTGS2—Prostaglandin Synthesis and Regulation—PRL—schizophrenia	0.000691	0.00775	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—PLXNA2—schizophrenia	0.000683	0.00765	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—SMARCA2—schizophrenia	0.000679	0.00761	CbGpPWpGaD
Lenalidomide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—schizophrenia	0.000678	0.0076	CbGpPWpGaD
Lenalidomide—CDH5—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—schizophrenia	0.000632	0.00708	CbGpPWpGaD
Lenalidomide—ABCB1—brain—schizophrenia	0.000606	0.00371	CbGeAlD
Lenalidomide—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—schizophrenia	0.000579	0.00649	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—DGKI—schizophrenia	0.000561	0.00629	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—schizophrenia	0.000537	0.00602	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—MBP—schizophrenia	0.000517	0.0058	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PPP1R1B—schizophrenia	0.000513	0.00575	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—schizophrenia	0.000512	0.00574	CbGpPWpGaD
Lenalidomide—PTGS2—Arachidonic acid metabolism—CYP1A2—schizophrenia	0.000502	0.00563	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—MEF2C—schizophrenia	0.000498	0.00558	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—RTN4—schizophrenia	0.000487	0.00545	CbGpPWpGaD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—schizophrenia	0.000485	0.00543	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FZD3—schizophrenia	0.000477	0.00535	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—MAG—schizophrenia	0.000461	0.00517	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FES—schizophrenia	0.000449	0.00503	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PPP3CC—schizophrenia	0.000449	0.00503	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—GRM2—schizophrenia	0.000449	0.00503	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TAAR6—schizophrenia	0.000449	0.00503	CbGpPWpGaD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—AKT1—schizophrenia	0.00044	0.00493	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—MAD1L1—schizophrenia	0.000431	0.00483	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOS—schizophrenia	0.000421	0.00472	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—AKT1—schizophrenia	0.000415	0.00465	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NGEF—schizophrenia	0.000415	0.00465	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NTS—schizophrenia	0.000406	0.00455	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—schizophrenia	0.000402	0.00451	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—GFAP—schizophrenia	0.000397	0.00444	CbGpPWpGaD
Lenalidomide—PTGS2—Arachidonic acid metabolism—PLA2G4A—schizophrenia	0.000385	0.00431	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—GRIN1—schizophrenia	0.000384	0.0043	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—RGS4—schizophrenia	0.000381	0.00427	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—GRM3—schizophrenia	0.000381	0.00427	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—RTN4—schizophrenia	0.000381	0.00427	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HTR6—schizophrenia	0.000374	0.0042	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MAG—schizophrenia	0.000362	0.00405	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—HSPA8—schizophrenia	0.000362	0.00405	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CHRM1—schizophrenia	0.000331	0.00371	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—ESR1—schizophrenia	0.000323	0.00362	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL3RA—schizophrenia	0.000322	0.00361	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—TNF—schizophrenia	0.000318	0.00356	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NRG3—schizophrenia	0.000315	0.00353	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TLE1—schizophrenia	0.000315	0.00353	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—GFAP—schizophrenia	0.000311	0.00348	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—GRM5—schizophrenia	0.000307	0.00345	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TLE3—schizophrenia	0.000298	0.00334	CbGpPWpGaD
Lenalidomide—ABCB1—ABC-family proteins mediated transport—APOA1—schizophrenia	0.000289	0.00323	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCK—schizophrenia	0.000281	0.00315	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PDE4B—schizophrenia	0.000274	0.00307	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—schizophrenia	0.000273	0.00305	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCKAR—schizophrenia	0.00027	0.00302	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ADORA2A—schizophrenia	0.000261	0.00293	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—GSTM1—schizophrenia	0.000254	0.00285	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-E—schizophrenia	0.000253	0.00283	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FGA—schizophrenia	0.000251	0.00281	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—NOS1—schizophrenia	0.000249	0.00279	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—SOD2—schizophrenia	0.000246	0.00275	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NPY—schizophrenia	0.000244	0.00274	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NOTCH4—schizophrenia	0.000244	0.00274	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ATP2A2—schizophrenia	0.000244	0.00274	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HTR1B—schizophrenia	0.000236	0.00264	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—OXT—schizophrenia	0.000236	0.00264	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HTR1A—schizophrenia	0.000227	0.00254	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NPS—schizophrenia	0.000223	0.0025	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—DRD1—schizophrenia	0.000219	0.00246	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HTR2C—schizophrenia	0.000219	0.00246	CbGpPWpGaD
Lenalidomide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—schizophrenia	0.000218	0.00245	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—MTHFR—schizophrenia	0.000216	0.00243	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NTRK2—schizophrenia	0.000213	0.00239	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—DRD3—schizophrenia	0.000212	0.00238	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—DRD4—schizophrenia	0.000206	0.00231	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	0.000203	0.00228	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	0.000203	0.00228	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—BDNF—schizophrenia	0.000203	0.00227	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—APOA1—schizophrenia	0.000199	0.00223	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CNR1—schizophrenia	0.000197	0.0022	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—EP300—schizophrenia	0.000193	0.00216	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HTR7—schizophrenia	0.000192	0.00215	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—DRD2—schizophrenia	0.000192	0.00215	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL10—schizophrenia	0.000189	0.00212	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PRL—schizophrenia	0.000181	0.00203	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—schizophrenia	0.000172	0.00193	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—S100B—schizophrenia	0.000169	0.00189	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	0.000163	0.00182	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ERBB4—schizophrenia	0.000162	0.00181	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—schizophrenia	0.000157	0.00176	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—FOS—schizophrenia	0.000155	0.00173	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—FXYD6—schizophrenia	0.000154	0.00172	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PLA2G4A—schizophrenia	0.000152	0.0017	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NRG1—schizophrenia	0.000149	0.00167	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MEF2C—schizophrenia	0.000148	0.00166	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—schizophrenia	0.000147	0.00164	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—YWHAZ—schizophrenia	0.000143	0.0016	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ERBB3—schizophrenia	0.00014	0.00156	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	0.000138	0.00155	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—FOS—schizophrenia	0.000137	0.00154	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	0.000136	0.00152	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HTR2A—schizophrenia	0.000134	0.00151	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PRODH—schizophrenia	0.000134	0.0015	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	0.000132	0.00148	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL1B—schizophrenia	0.000128	0.00144	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—APOE—schizophrenia	0.000125	0.0014	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—APOA1—schizophrenia	0.000124	0.00138	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.000123	0.00138	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ESR1—schizophrenia	0.000119	0.00134	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—EP300—schizophrenia	0.000119	0.00134	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—HTR3A—schizophrenia	0.000117	0.00131	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NDST3—schizophrenia	0.000114	0.00128	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MPC2—schizophrenia	0.000109	0.00122	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—GSK3B—schizophrenia	0.000108	0.00121	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC1A1—schizophrenia	0.000104	0.00116	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	0.000103	0.00116	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—EP300—schizophrenia	0.000102	0.00115	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.000102	0.00114	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1B—schizophrenia	0.000102	0.00114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLCH2—schizophrenia	0.000102	0.00114	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL1B—schizophrenia	9.93e-05	0.00111	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IPO5—schizophrenia	9.89e-05	0.00111	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	9.78e-05	0.0011	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NDST3—schizophrenia	9.55e-05	0.00107	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PRODH—schizophrenia	9.5e-05	0.00106	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC17A7—schizophrenia	9.5e-05	0.00106	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	9.34e-05	0.00105	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—TNF—schizophrenia	9.32e-05	0.00104	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC27A5—schizophrenia	9.05e-05	0.00101	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ACSL6—schizophrenia	9.05e-05	0.00101	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	8.85e-05	0.000992	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DAO—schizophrenia	8.64e-05	0.000968	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—GABRB2—schizophrenia	8.42e-05	0.000944	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PNP—schizophrenia	8.28e-05	0.000928	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MPC2—schizophrenia	7.75e-05	0.000868	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NDUFV2—schizophrenia	7.7e-05	0.000863	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TNF—schizophrenia	7.37e-05	0.000826	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	7.34e-05	0.000822	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC18A2—schizophrenia	7.27e-05	0.000815	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIP4K2A—schizophrenia	7.24e-05	0.000811	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—TNF—schizophrenia	7.2e-05	0.000807	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLCH2—schizophrenia	7.2e-05	0.000807	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	7.18e-05	0.000804	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—EP300—schizophrenia	7.12e-05	0.000798	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NDST3—schizophrenia	6.77e-05	0.000759	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC6A1—schizophrenia	6.69e-05	0.00075	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP26B1—schizophrenia	6.55e-05	0.000734	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TP53—schizophrenia	6.5e-05	0.000728	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC27A5—schizophrenia	6.42e-05	0.000719	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ACSL6—schizophrenia	6.42e-05	0.000719	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—AKT1—schizophrenia	6.19e-05	0.000694	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	6.18e-05	0.000692	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DAO—schizophrenia	6.12e-05	0.000686	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NRG3—schizophrenia	6.06e-05	0.000679	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TLE1—schizophrenia	6.06e-05	0.000679	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ATP2A2—schizophrenia	5.96e-05	0.000668	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PNP—schizophrenia	5.87e-05	0.000658	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—TPH1—schizophrenia	5.83e-05	0.000654	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GCLM—schizophrenia	5.83e-05	0.000654	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TLE3—schizophrenia	5.74e-05	0.000643	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	5.5e-05	0.000617	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PRKD1—schizophrenia	5.49e-05	0.000615	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GAPDH—schizophrenia	5.47e-05	0.000613	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NDUFV2—schizophrenia	5.46e-05	0.000612	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIP4K2A—schizophrenia	5.13e-05	0.000575	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TP53—schizophrenia	5.1e-05	0.000571	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	5.01e-05	0.000562	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FGA—schizophrenia	4.83e-05	0.000541	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	4.77e-05	0.000534	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP26B1—schizophrenia	4.64e-05	0.00052	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GAPDH—schizophrenia	4.58e-05	0.000513	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CLOCK—schizophrenia	4.54e-05	0.000508	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	4.53e-05	0.000507	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	4.47e-05	0.000501	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—TPH2—schizophrenia	4.42e-05	0.000495	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CACNB2—schizophrenia	4.42e-05	0.000495	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	4.42e-05	0.000495	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	4.38e-05	0.000491	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DPYD—schizophrenia	4.35e-05	0.000487	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AKT1—schizophrenia	4.3e-05	0.000482	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SNAP25—schizophrenia	4.22e-05	0.000473	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TPH1—schizophrenia	4.14e-05	0.000463	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GCLM—schizophrenia	4.14e-05	0.000463	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CACNA1C—schizophrenia	4.04e-05	0.000453	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3C2A—schizophrenia	3.94e-05	0.000442	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PRKD1—schizophrenia	3.89e-05	0.000436	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HSPA1A—schizophrenia	3.79e-05	0.000425	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS1—schizophrenia	3.76e-05	0.000422	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	3.73e-05	0.000418	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	3.55e-05	0.000398	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SNAP25—schizophrenia	3.53e-05	0.000396	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP2D6—schizophrenia	3.53e-05	0.000396	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PRL—schizophrenia	3.49e-05	0.000391	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GAPDH—schizophrenia	3.25e-05	0.000364	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CLOCK—schizophrenia	3.22e-05	0.00036	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP1A2—schizophrenia	3.2e-05	0.000358	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—TH—schizophrenia	3.15e-05	0.000353	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CACNB2—schizophrenia	3.13e-05	0.000351	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TPH2—schizophrenia	3.13e-05	0.000351	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	3.13e-05	0.000351	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ERBB4—schizophrenia	3.11e-05	0.000349	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DPYD—schizophrenia	3.08e-05	0.000346	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	3.02e-05	0.000338	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NRG1—schizophrenia	2.87e-05	0.000322	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CACNA1C—schizophrenia	2.87e-05	0.000321	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3C2A—schizophrenia	2.79e-05	0.000313	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—YWHAZ—schizophrenia	2.75e-05	0.000308	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ERBB3—schizophrenia	2.69e-05	0.000301	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—COMT—schizophrenia	2.68e-05	0.0003	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTP1—schizophrenia	2.67e-05	0.000299	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MAOA—schizophrenia	2.66e-05	0.000298	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	2.65e-05	0.000297	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MTHFR—schizophrenia	2.59e-05	0.00029	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.58e-05	0.000289	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCB1—schizophrenia	2.52e-05	0.000283	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP2D6—schizophrenia	2.51e-05	0.000281	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SNAP25—schizophrenia	2.51e-05	0.000281	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLA2G4A—schizophrenia	2.45e-05	0.000275	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTM1—schizophrenia	2.45e-05	0.000275	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOE—schizophrenia	2.41e-05	0.00027	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOA1—schizophrenia	2.38e-05	0.000267	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP1A2—schizophrenia	2.27e-05	0.000254	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TH—schizophrenia	2.23e-05	0.00025	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MTHFR—schizophrenia	2.17e-05	0.000243	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GSK3B—schizophrenia	2.08e-05	0.000234	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOE—schizophrenia	2.02e-05	0.000226	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOA1—schizophrenia	1.99e-05	0.000223	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—COMT—schizophrenia	1.9e-05	0.000213	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTP1—schizophrenia	1.89e-05	0.000212	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MAOA—schizophrenia	1.89e-05	0.000211	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTM1—schizophrenia	1.74e-05	0.000195	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLA2G4A—schizophrenia	1.74e-05	0.000195	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MTHFR—schizophrenia	1.54e-05	0.000172	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOE—schizophrenia	1.43e-05	0.00016	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOA1—schizophrenia	1.41e-05	0.000158	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—EP300—schizophrenia	1.37e-05	0.000154	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—EP300—schizophrenia	1.15e-05	0.000129	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKT1—schizophrenia	8.29e-06	9.29e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—EP300—schizophrenia	8.14e-06	9.13e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AKT1—schizophrenia	6.94e-06	7.78e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AKT1—schizophrenia	4.92e-06	5.51e-05	CbGpPWpGaD
